Skip to content

Clinical trials

Phase 2 Dementia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 2 Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20044
20054
20066
20078
20085
20093
20107
20118
20125
20135
20141
20155
20164
201711
20189
20194
20206
20218
202210
202312
202410
202513
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Recruiting17
Terminated14
Active, not recruiting11
Unknown status10
Withdrawn7
Not yet recruiting5
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital6
AbbVie3
Alkahest, Inc.3
Eli Lilly and Company3
Inmune Bio, Inc.3
Johns Hopkins University3
National Institute of Neurological Disorders and Stroke (NINDS)3
Alzheimer's Disease Cooperative Study (ADCS)2
Arctic Therapeutics2
Avraham Pharmaceuticals Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia162
Alzheimer Disease102
Cognitive Dysfunction42
Brain Diseases23
Mental Disorders22
Neurodegenerative Diseases20
Central Nervous System Diseases19
Nervous System Diseases18
Memory Disorders14
Tauopathies13

Trials

Showing 26 to 50 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.